Fiduciary Trust Co Has $63.71 Million Stake in The Procter & Gamble Company (NYSE:PG)

Fiduciary Trust Co increased its stake in The Procter & Gamble Company (NYSE:PG) by 0.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 367,831 shares of the company’s stock after purchasing an additional 1,564 shares during the period. Procter & Gamble accounts for 0.9% of Fiduciary Trust Co’s portfolio, making the stock its 20th largest holding. Fiduciary Trust Co’s holdings in Procter & Gamble were worth $63,708,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. bought a new stake in shares of Procter & Gamble during the second quarter worth approximately $28,000. Fairway Wealth LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble in the 3rd quarter worth $33,000. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble during the second quarter worth $34,000. Finally, Quest Partners LLC acquired a new position in Procter & Gamble in the second quarter valued at about $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of Procter & Gamble stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This represents a 2.54 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 35,233 shares of company stock valued at $6,024,234 in the last quarter. 0.18% of the stock is currently owned by insiders.

Procter & Gamble Price Performance

Shares of PG opened at $179.34 on Thursday. The Procter & Gamble Company has a twelve month low of $142.50 and a twelve month high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a 50 day moving average of $170.22 and a 200-day moving average of $168.90. The stock has a market capitalization of $422.35 billion, a P/E ratio of 30.92, a P/E/G ratio of 3.82 and a beta of 0.42.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the business earned $1.83 earnings per share. The firm’s revenue was down .6% on a year-over-year basis. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.96 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.24%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio is 69.48%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on PG. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. lifted their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Evercore ISI increased their price target on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a report on Monday, October 21st. Finally, DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a research report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $180.45.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.